home

RefleXion Announces Licensing Agreement with Mirada Medical to Advance Personalized Cancer Treatment

Rapid, adaptive radiotherapy treatment plans hold potential to reduce toxicity and improve patient outcomes HAYWARD, Calif., July 7, 2022...

Apposite Capital Makes Further Investment in Mirada Medical to Advance Precision Cancer Care

London, UK – 8th June 2022. Apposite Capital, the healthcare specialist private equity investor, today announces that it has made a...

Sorna Corporation Now Offering PET/CT Fusion Viewer

EAGAN, MN – June 8, 2022– Sorna Corporation continues to innovate enterprise imaging with the announcement of its partnership with Mirada...

Pioneering Personalized Cancer Care – Article with Healthcare Tech

Mirada Medical Pioneering Personalized Cancer Care “Everybody’s cancer is unique, requiring a personalized and precise treatment,” says...